149 related articles for article (PubMed ID: 33772241)
21. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases.
Jakobiec FA; Rini FJ; Fraunfelder FT; Brownstein S
Ophthalmology; 1988 Aug; 95(8):1058-70. PubMed ID: 3231444
[TBL] [Abstract][Full Text] [Related]
22. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases.
De Potter P; Shields CL; Shields JA; Menduke H
Br J Ophthalmol; 1993 Oct; 77(10):624-30. PubMed ID: 8218029
[TBL] [Abstract][Full Text] [Related]
23. Conjunctival Melanoma in 430 Cases: Comparative Analysis of the Impact of Orbital Invasion on Tumor Recurrence, Metastasis, and Death.
Bas Z; Dockery PW; Lally SE; Shields JA; Shields CL
Ophthalmic Plast Reconstr Surg; 2023 Jan-Feb 01; 39(1):49-57. PubMed ID: 36598390
[TBL] [Abstract][Full Text] [Related]
24. [Clinical findings and prognosis of 11 cases of conjunctival malignant melanoma].
Kimura K; Usui Y; Goto H
Nippon Ganka Gakkai Zasshi; 2012 May; 116(5):503-9. PubMed ID: 22690541
[TBL] [Abstract][Full Text] [Related]
25. Malignant melanoma arising from unusual conjunctival blue nevus.
Demirci H; Shields CL; Shields JA; Eagle RC
Arch Ophthalmol; 2000 Nov; 118(11):1581-4. PubMed ID: 11074819
[TBL] [Abstract][Full Text] [Related]
26. Conjunctival melanoma: Risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center.
Vaidya S; Dalvin LA; Yaghy A; Pacheco R; Shields JA; Lally SE; Shields CL
Eur J Ophthalmol; 2021 Sep; 31(5):2675-2685. PubMed ID: 33176471
[TBL] [Abstract][Full Text] [Related]
27. Clinical features predictive of orbital exenteration for conjunctival melanoma.
Shields JA; Shields CL; Gündüz K; Cater J
Ophthalmic Plast Reconstr Surg; 2000 May; 16(3):173-8. PubMed ID: 10826757
[TBL] [Abstract][Full Text] [Related]
28. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
[TBL] [Abstract][Full Text] [Related]
29. Conjunctival nevus and melanoma.
Furdova A; Pesko K; Strmen P; Kobzova M
Bratisl Lek Listy; 2007; 108(7):287-91. PubMed ID: 17972544
[TBL] [Abstract][Full Text] [Related]
30. Progression of conjunctival primary acquired melanosis (PAM) to widely spreaded malignant melanoma.
Jandroković S; Popović-Suić S; Mandić JJ; Kuzman T; Skegro I; Kutija MB; Masnec S; Kalauz M
Coll Antropol; 2014 Dec; 38(4):1187-90. PubMed ID: 25842754
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
[TBL] [Abstract][Full Text] [Related]
32. [Conjunctival melanoma at corneoscleral limbus on primary acquired melanosis. A case report].
Chazalon-Pauleau E; Roux L; Patte JH; Pommier S; Bonnet D; Meyer F
J Fr Ophtalmol; 2007 Oct; 30(8):e22. PubMed ID: 17978670
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and pathological features of 26 cases of conjunctival melanoma].
Lin JY; Liu D; Li EJ
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):308-11. PubMed ID: 20654056
[TBL] [Abstract][Full Text] [Related]
34. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
Kurli M; Finger PT
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
[TBL] [Abstract][Full Text] [Related]
35. Management of conjunctival melanoma.
Damato B; Coupland SE
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1227-39. PubMed ID: 19761427
[TBL] [Abstract][Full Text] [Related]
36. Population-based incidence of conjunctival tumours in Olmsted County, Minnesota.
Dalvin LA; Salomão DR; Patel SV
Br J Ophthalmol; 2018 Dec; 102(12):1728-1734. PubMed ID: 29511061
[TBL] [Abstract][Full Text] [Related]
37. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
[TBL] [Abstract][Full Text] [Related]
38. Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma.
Seregard S
J Clin Pathol; 1996 Apr; 49(4):338-42. PubMed ID: 8655713
[TBL] [Abstract][Full Text] [Related]
39. Validation of the Newly Proposed World Health Organization Classification System for Conjunctival Melanocytic Intraepithelial Lesions: A Comparison with the C-MIN and PAM Classification Schemes.
Milman T; Eiger-Moscovich M; Henry RK; Folberg R; Coupland SE; Grossniklaus HE; Mudhar HS; Eberhart CG; Heegaard S; Auw-Hädrich C; Herwig-Carl MC; Löffler KU; Cherepanoff S; Zhang Q; Sharpe JE; See TRO; Shields CL; Eagle RC
Am J Ophthalmol; 2021 Mar; 223():60-74. PubMed ID: 33130046
[TBL] [Abstract][Full Text] [Related]
40. [Focus on clinical and pathological management of conjunctival melanocytic tumors].
Lassalle S; Caujolle JP; Leger F; Maschi C; Gastaud L; Nahon-Esteve S; Thariat J; Baillif S; Hofman P
Ann Pathol; 2018 Jun; 38(3):153-163. PubMed ID: 29803361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
